← Leaderboards
Yuanxiang Zhao
California State Poly U Pomona
$850,754
Attributed
$850,754
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $108.8K · FY2010–19$200K$150K$100K$50K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$850,754 · 2
By mechanism
SC3$850,754 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsOsteocytesEventLipid BiosynthesisMolecularObesityCell TypeEnvironmental ChemicalFatty Acid Glycerol EstersIn VitroMesenchymal Stem CellsMicroarray AnalysisAdipocytesNormal Tissue MorphologyAdipose TissueCellsBaseDiabetes MellitusAdult Stem CellBone CellGenesHomeostasisAdverse EffectsPharmacologic Substance
Grant awards (8)
Molecular and Cellular Profiling of Human Adipogensis$108,750
SC3 · FY2019 · GM · contact PI
Molecular and Cellular Profiling of Human Adipogensis$108,750
SC3 · FY2018 · GM · contact PI
Molecular and Cellular Profiling of Human Adipogensis$108,750
SC3 · FY2017 · GM · contact PI
Molecular and Cellular Profiling of Human Adipogensis$108,750
SC3 · FY2016 · GM · contact PI
Adipogenic Toxicity Study of Obesogenic Drugs$101,744
SC3 · FY2013 · GM · contact PI
Adipogenic Toxicity Study of Obesogenic Drugs$105,435
SC3 · FY2012 · GM · contact PI
Adipogenic Toxicity Study of Obesogenic Drugs$105,435
SC3 · FY2011 · GM · contact PI
Adipogenic Toxicity Study of Obesogenic Drugs$103,140
SC3 · FY2010 · GM · contact PI